comparemela.com

Latest Breaking News On - Jim boylan - Page 4 : comparemela.com

Investegate |Zenas BioPharma Announcements | Zenas BioPharma: Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics

Investegate announcements from Zenas BioPharma, Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics

Wellington
New-zealand-general
New-zealand
Waltham
Leicestershire
United-kingdom
Zenas-biopharma
James-boylan
Hongbo-lu
Jim-boylan
Tellus-bioventures
Patrick-enright

Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics

Proceeds to fund global Phase 3 registration program for the company's lead product candidate, Obexelimab, and support the clinical development of other pipeline programsSeries B equity financing led by

Wellington
New-zealand-general
New-zealand
Zenas-biopharma
Jim-boylan
Tellus-bioventures
Kostenloser-wertpapierhandel
James-boylan
Hongbo-lu
Zenasbiopharmaand-linkedin
Patrick-enright
Xencor-inc

vimarsana © 2020. All Rights Reserved.